Halozyme Therapeutics, Inc. SEC filings HALO
Halozyme Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jan 9, 2012. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Jul 21, 2023 | — |
| CORRESP | Letter to the SEC | Jun 28, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2023 | — |
| SC TO-T/A | Filing | May 24, 2022 | — |
| SC TO-T/A | Filing | May 12, 2022 | — |
| SC TO-T/A | Filing | May 2, 2022 | — |
| SC TO-T | Filing | Apr 26, 2022 | — |
| SC TO-C | Filing | Apr 14, 2022 | — |
| SC TO-C | Filing | Apr 13, 2022 | — |
| SC TO-C | Filing | Apr 13, 2022 | — |
| CT ORDER | Filing | Dec 20, 2018 | — |
| CT ORDER | Filing | Jun 14, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2016 | — |
| CORRESP | Letter to the SEC | Jan 4, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2015 | — |
| CORRESP | Letter to the SEC | Nov 20, 2015 | — |
| CORRESP | Letter to the SEC | Oct 28, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2015 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2014 | — |
| CORRESP | Letter to the SEC | Jan 17, 2014 | — |
| CT ORDER | Filing | Dec 31, 2013 | — |
| CORRESP | Letter to the SEC | Dec 26, 2013 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2013 | — |
| UPLOAD | Letter from the SEC | Oct 16, 2012 | — |
| CORRESP | Letter to the SEC | Oct 9, 2012 | — |
| UPLOAD | Letter from the SEC | Oct 3, 2012 | — |
| CORRESP | Letter to the SEC | Aug 31, 2012 | — |
| CORRESP | Letter to the SEC | Aug 8, 2012 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2012 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- HALO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1159036
- Former names
- HALOZYME THERAPEUTICS INC (until Jul 3, 2019); GLOBAL YACHT SERVICES INC (until Mar 12, 2004)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.